Epstein-Barr Virus Infections - 25 Studies Found
Active, not recruiting |
: Efficacy of Recombinant Epstein-Barr Virus (EBV) Vaccine in Patients With Nasopharyngeal Cancer Who Had Residual EBV DNA Load After Conventional Therapy :
: 2010-03-26 : Biological: Recombinant Epstein-Barr Virus (EBV) Vaccine |
Recruiting |
: A Study of the Safety and Efficacy of EBV Specific T-cell Lines :
|
Completed |
: Activity of Valomaciclovir in Infectious Mononucleosis Due to Primary Epstein-Barr Virus Infection : Infectious Mononucleosis : 2007-12-14 :
|
Completed |
: Modified Vaccinia Ankara (MVA) Vaccine Study :
: Drug: MVA Vaccine The starting dose will be 5 x 107 plaque forming units (pfu) given by intradermal vacc |
Completed |
: EBV-Specific CTLs Following CD45 Antibody to Patients With Epstein-Barr Virus (EBV) + Nasopharyngeal Carcinoma (NPC) :
: 2004-03-01 :
|
Completed |
: Most Closely HLA Matched Allogeneic Virus Specific Cytotoxic T-Lymphocytes (CTL) :
: 2008-06-20 : Biological: Trivirus Specific CTLs for EBV, CMV and Adenovirus Infection |
Completed |
: The Prevelance Rate of Human Cytomegalovirus (HCMV), Epstein-Barr Virus (EBV) and Human Herpes Virus (HHV-6) in a Saliva of the Patient With Periodantitis :
: |
Recruiting |
: Using Multi-virus Cytotoxic T-cells Following T-Cell Depleted Allogeneic HPCT for Prophylaxis Against Epstein Barr Virus, Adenovirus, And Cytomegalovirus :
|